{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Midazolam+3+mg&page=2", "query": { "intervention": "Midazolam 3 mg", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Midazolam+3+mg&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-29T04:26:00.671Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03199339", "title": "A Phase 1 Study to Evaluate Safety, Tolerability, PK, and PK Interactions of TBA-7371", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Tuberculosis", "Tuberculosis, Pulmonary" ], "interventions": [ { "name": "TBA-7371", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Global Alliance for TB Drug Development", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "19 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "19 Years to 50 Years" }, "enrollment_count": 74, "start_date": "2017-08-29", "completion_date": "2018-07-08", "has_results": false, "last_update_posted_date": "2018-10-17", "last_synced_at": "2026-09-29T04:26:00.671Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03199339" }, { "nct_id": "NCT05126459", "title": "A Comparison of Oral Sedation-related Events of Three Multiagent Oral Sedation Regimens in Pediatric Dental Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Anxiety, Dental", "Dental Decay" ], "interventions": [ { "name": "Regimen 1", "type": "COMBINATION_PRODUCT" }, { "name": "Regimen #2", "type": "COMBINATION_PRODUCT" }, { "name": "Regimen #3", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "Loma Linda University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "7 Years", "sex": "ALL", "summary": "3 Years to 7 Years" }, "enrollment_count": 60, "start_date": "2022-02-14", "completion_date": "2023-04-12", "has_results": true, "last_update_posted_date": "2024-10-02", "last_synced_at": "2026-09-29T04:26:00.671Z", "location_count": 1, "location_summary": "Loma Linda, California", "locations": [ { "city": "Loma Linda", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05126459" }, { "nct_id": "NCT00744380", "title": "Dexmedetomidine Versus Midazolam for Facilitating Extubation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Critical Illness" ], "interventions": [ { "name": "Midazolam", "type": "DRUG" }, { "name": "Dexmedetomidine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 23, "start_date": "2008-08", "completion_date": "2012-10", "has_results": true, "last_update_posted_date": "2016-09-28", "last_synced_at": "2026-09-29T04:26:00.671Z", "location_count": 1, "location_summary": "Aurora, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00744380" }, { "nct_id": "NCT04766996", "title": "PROUD Study - Preventing Opioid Use Disorders", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Anesthesia", "Opioid Use" ], "interventions": [ { "name": "Guided mindfulness exercises", "type": "BEHAVIORAL" }, { "name": "Self-administered aromatherapy", "type": "OTHER" }, { "name": "Baby aspirin", "type": "DRUG" }, { "name": "Tylenol/Acetaminophen", "type": "DRUG" }, { "name": "Pregabalin", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Meloxicam", "type": "DRUG" }, { "name": "Prilosec", "type": "DRUG" }, { "name": "Tramadol", "type": "DRUG" }, { "name": "Voltaren", "type": "DRUG" }, { "name": "Zofran", "type": "DRUG" }, { "name": "Pepcid", "type": "DRUG" }, { "name": "Reglan", "type": "DRUG" }, { "name": "Versed", "type": "DRUG" }, { "name": "Lidocaine", "type": "DRUG" }, { "name": "Propofol", "type": "DRUG" }, { "name": "Ancef", "type": "DRUG" }, { "name": "Tranexamic Acid (TXA)", "type": "DRUG" }, { "name": "Decadron", "type": "DRUG" }, { "name": "Bupivacaine hydrochloride", "type": "DRUG" }, { "name": "Toradol", "type": "DRUG" } ], "intervention_types": [ "BEHAVIORAL", "OTHER", "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 57, "start_date": "2021-05-17", "completion_date": "2021-12-27", "has_results": true, "last_update_posted_date": "2023-06-22", "last_synced_at": "2026-09-29T04:26:00.671Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04766996" }, { "nct_id": "NCT01566838", "title": "Continuous Subpleural Infusion of Bupivacaine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Postoperative Pain" ], "interventions": [ { "name": "Subpleural pain catheter with infusion of 0.125% bupivacaine", "type": "DRUG" }, { "name": "Standard acute pain management", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Inova Health Care Services", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 83, "start_date": "2012-10", "completion_date": "2015-12", "has_results": true, "last_update_posted_date": "2017-12-20", "last_synced_at": "2026-09-29T04:26:00.671Z", "location_count": 1, "location_summary": "Falls Church, Virginia", "locations": [ { "city": "Falls Church", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01566838" }, { "nct_id": "NCT04008186", "title": "A Clinical Drug-Drug Interaction (DDI) Study With Omaveloxolone", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Adult Subjects" ], "interventions": [ { "name": "Omaveloxolone", "type": "DRUG" }, { "name": "Midazolam oral solution", "type": "DRUG" }, { "name": "Repaglinide 1 MG", "type": "DRUG" }, { "name": "MetFORMIN 500 Mg Oral Tablet", "type": "DRUG" }, { "name": "Rosuvastatin", "type": "DRUG" }, { "name": "Digoxin tablet", "type": "DRUG" }, { "name": "Gemfibrozil Tablets", "type": "DRUG" }, { "name": "Itraconazole capsule", "type": "DRUG" }, { "name": "Verapamil Pill", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biogen", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 61, "start_date": "2019-06-14", "completion_date": "2019-08-28", "has_results": false, "last_update_posted_date": "2025-05-30", "last_synced_at": "2026-09-29T04:26:00.671Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04008186" }, { "nct_id": "NCT02147808", "title": "A Open-Label Drug-Drug Interaction Study of Telotristat Etiprate and Midazolam in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Drug Interactions" ], "interventions": [ { "name": "Telotristat etiprate", "type": "DRUG" }, { "name": "Midazolam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Lexicon Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 24, "start_date": "2014-05", "completion_date": null, "has_results": false, "last_update_posted_date": "2014-09-08", "last_synced_at": "2026-09-29T04:26:00.671Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT02147808" }, { "nct_id": "NCT03637049", "title": "Effect of PBI-4050 on the Pharmacokinetics of Midazolam in Heathy Adult Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "PBI-4050 and midazolam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Liminal BioSciences Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 22, "start_date": "2018-07-17", "completion_date": "2018-08-22", "has_results": false, "last_update_posted_date": "2020-12-08", "last_synced_at": "2026-09-29T04:26:00.671Z", "location_count": 1, "location_summary": "Tempe, Arizona", "locations": [ { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT03637049" }, { "nct_id": "NCT04586985", "title": "Safety, Tolerability and Pharmacokinetics of FTX-6058", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Adult Subjects", "Sickle Cell Disease" ], "interventions": [ { "name": "FTX-6058/placebo oral capsule(s)", "type": "DRUG" }, { "name": "FTX-6058 - Two Dosing Periods", "type": "DRUG" }, { "name": "FTX-6058 / Midazolam Syrup", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Fulcrum Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 109, "start_date": "2020-10-26", "completion_date": "2022-11-15", "has_results": false, "last_update_posted_date": "2022-12-12", "last_synced_at": "2026-09-29T04:26:00.671Z", "location_count": 2, "location_summary": "Atlanta, Georgia • Overland Park, Kansas", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Overland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04586985" }, { "nct_id": "NCT06383273", "title": "A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cataract" ], "interventions": [ { "name": "MELT-300 sublingual tablet", "type": "DRUG" }, { "name": "Midalozam sublingual tablet", "type": "DRUG" }, { "name": "Placebo sublingual tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Melt Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 528, "start_date": "2024-05-01", "completion_date": "2025-01", "has_results": false, "last_update_posted_date": "2024-08-02", "last_synced_at": "2026-09-29T04:26:00.671Z", "location_count": 12, "location_summary": "Chico, California • Grand Junction, Colorado • Jacksonville, Florida + 9 more", "locations": [ { "city": "Chico", "state": "California" }, { "city": "Grand Junction", "state": "Colorado" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Hagerstown", "state": "Maryland" }, { "city": "Alexandria", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT06383273" } ] }